301367SZSE

Announcement of Resolutions from the 19th Meeting of the 3rd Board of Directors

BMC Medical Co., Ltd.·

✨ AI Summary

The 19th meeting of the 3rd Board of Directors of Beijing Ruimait Medical Technology Co., Ltd. was held on April 22, 2026. Key decisions included the approval of the 2025 annual report, financial statements, and various management reports. The board also approved plans for profit distribution, cash management using idle funds, and the application for a comprehensive credit limit from banks, all aimed at enhancing operational efficiency and shareholder returns.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Board Meeting Details

Beijing Ruimait Medical Technology Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of its 3rd Board of Directors on April 22, 2026, in a combined onsite and telecommunication format. The meeting notice was sent to all directors in writing and via email on April 9, 2026. The meeting was convened and presided over by Mr. Zhuang Zhi, the Chairman of the Company. A total of 9 directors were required to attend, and all 9 directors were present, with Mr. Zhou Mingzhao, Mr. Cui Wenli, Mr. Tan Ching, Mr. Ku Yixuan, Mr. Li Yang, and Mr. Sun Peirui attending via telecommunication. Senior management also attended the meeting. The meeting complied with relevant laws, regulations, and the Company's Articles of Association.

II. Meeting Resolutions

After thorough discussion among all attending directors, the following proposals were reviewed and approved:

  1. Proposal on the Full Text and Summary of the Company's 2025 Annual Report

    • The Board believes that the preparation and review procedures for the 2025 Annual Report and its summary comply with legal and regulatory requirements, accurately reflecting the Company's operational status for the year. The proposal was approved by the Audit Committee of the Board.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions.

  2. Proposal on the Company's 2025 Annual Board Work Report

    • The Board agreed to disclose the 2025 Annual Board Work Report, summarizing the Board's work for the year. Independent directors submitted their reports, which will be presented at the 2025 Annual Shareholders' Meeting.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions. This proposal requires approval at the shareholders' meeting.

  3. Proposal on the Company's 2025 Annual General Manager Work Report

    • The Board found the report to accurately reflect the Company's operational status and management's adherence to resolutions made by the shareholders and Board.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions.

  4. Proposal on the Company's 2025 Annual Internal Control Self-Evaluation Report

    • The Board deemed the report to objectively reflect the internal control system's construction and operation.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions.

  5. Proposal on the Company's 2025 Annual Financial Settlement Report

    • The Board found the report to objectively reflect the Company's financial status and operational results.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions.

  6. Proposal on the Company's 2025 Annual Special Report on the Storage and Use of Raised Funds

    • The Board confirmed compliance with relevant regulations regarding the storage and use of raised funds.
    • Voting Results: 9 votes in favor, 0 votes against, 0 abstentions.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing